These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 30098225)

  • 21. Dental pulp mesenchymal stem/stromal cells labeled with iron sucrose release exosomes and cells applied intra-nasally migrate to intracerebral glioblastoma.
    Altanerova U; Benejova K; Altanerova V; Tyciakova S; Rychly B; Szomolanyi P; Ciampor F; Cihova M; Repiska V; Ondicova K; Mravec B; Altaner C
    Neoplasma; 2016; 63(6):925-933. PubMed ID: 27565330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mesenchymal stem cells expressing cytosine deaminase inhibit growth of murine melanoma B16F10 in vivo].
    Krasikova LS; Karshieva SS; Cheglakov IB; Belyavsky AV
    Mol Biol (Mosk); 2015; 49(6):1007-15. PubMed ID: 26710783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanoscale bubble ultrasound contrast agents-mediated suicide gene therapy system, Nanoscale bubble-LV5-YCD-TK/GCV/5-FC, effectively inhibits bladder cancer cell growth.
    Fu YR; Chen F; Luo Y; Yi YF
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):75-86. PubMed ID: 30657549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy.
    Kucerova L; Altanerova V; Matuskova M; Tyciakova S; Altaner C
    Cancer Res; 2007 Jul; 67(13):6304-13. PubMed ID: 17616689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complete regression of glioblastoma by mesenchymal stem cells mediated prodrug gene therapy simulating clinical therapeutic scenario.
    Altaner C; Altanerova V; Cihova M; Ondicova K; Rychly B; Baciak L; Mravec B
    Int J Cancer; 2014 Mar; 134(6):1458-65. PubMed ID: 24038033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concomitant expression of E. coli cytosine deaminase and uracil phosphoribosyltransferase improves the cytotoxicity of 5-fluorocytosine.
    Tiraby M; Cazaux C; Baron M; Drocourt D; Reynes JP; Tiraby G
    FEMS Microbiol Lett; 1998 Oct; 167(1):41-9. PubMed ID: 9785450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic effects of genetically engineered stem cells expressing cytosine deaminase and interferon-β via their tumor tropism to selectively target human hepatocarcinoma cells.
    Yi BR; Hwang KA; Kang NH; Kim SU; Jeung EB; Kim HC; Choi KC
    Cancer Gene Ther; 2012 Sep; 19(9):644-51. PubMed ID: 22790964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of 19F spectroscopy and diffusion-weighted MRI to evaluate differences in gene-dependent enzyme prodrug therapies.
    Hamstra DA; Lee KC; Tychewicz JM; Schepkin VD; Moffat BA; Chen M; Dornfeld KJ; Lawrence TS; Chenevert TL; Ross BD; Gelovani JT; Rehemtulla A
    Mol Ther; 2004 Nov; 10(5):916-28. PubMed ID: 15509509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytosine deaminase-producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model.
    You MH; Kim WJ; Shim W; Lee SR; Lee G; Choi S; Kim DY; Kim YM; Kim H; Han SU
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1393-400. PubMed ID: 19486256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased proliferation and chemosensitivity of human mesenchymal stromal cells expressing fusion yeast cytosine deaminase.
    Kucerova L; Poturnajova M; Tyciakova S; Matuskova M
    Stem Cell Res; 2012 Mar; 8(2):247-58. PubMed ID: 22265744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Photochemical Internalization Enhanced Nonviral Suicide Gene Therapy.
    Sun CH; Berg K; Hirschberg H
    Methods Mol Biol; 2019; 1895():165-176. PubMed ID: 30539537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A preliminary study on the construction of double suicide gene delivery vectors by mesenchymal stem cells and the in vitro inhibitory effects on SKOV3 cells.
    Jiang J; Wei D; Sun L; Wang Y; Wu X; Li Y; Fang Z; Shang H; Wei Z
    Oncol Rep; 2014 Feb; 31(2):781-7. PubMed ID: 24317390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exosomes of human mesenchymal stem/stromal/medicinal signaling cells.
    Altanerova U; Jakubechova J; Repiska V; Altaner C
    Neoplasma; 2017; 64(6):809-815. PubMed ID: 28895404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transduction of yeast cytosine deaminase mediated by HIV-1 Tat basic domain into tumor cells induces chemosensitivity to 5-fluorocytosine.
    Lee H; Ryu J; Kim KA; Lee KS; Lee JY; Park JB; Park J; Choi SY
    Exp Mol Med; 2004 Feb; 36(1):43-51. PubMed ID: 15031670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Product release is rate-limiting in the activation of the prodrug 5-fluorocytosine by yeast cytosine deaminase.
    Yao L; Li Y; Wu Y; Liu A; Yan H
    Biochemistry; 2005 Apr; 44(15):5940-7. PubMed ID: 15823054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative analysis of enzyme and pathway engineering strategies for 5FC-mediated suicide gene therapy applications.
    Johnson AJ; Ardiani A; Sanchez-Bonilla M; Black ME
    Cancer Gene Ther; 2011 Aug; 18(8):533-42. PubMed ID: 21394105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic effect of suicide gene-transferred mesenchymal stem cells in a rat model of glioma.
    Kosaka H; Ichikawa T; Kurozumi K; Kambara H; Inoue S; Maruo T; Nakamura K; Hamada H; Date I
    Cancer Gene Ther; 2012 Aug; 19(8):572-8. PubMed ID: 22744211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of the prodrugs 5-fluorocytosine and CPT-11 on ovarian cancer cells using genetically engineered stem cells: tumor-tropic potential and inhibition of ovarian cancer cell growth.
    Kim KY; Kim SU; Leung PC; Jeung EB; Choi KC
    Cancer Sci; 2010 Apr; 101(4):955-62. PubMed ID: 20704576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination of cytosine deaminase suicide gene expression with DR5 antibody treatment increases cancer cell cytotoxicity.
    Kaliberov SA; Chiz S; Kaliberova LN; Krendelchtchikova V; Della Manna D; Zhou T; Buchsbaum DJ
    Cancer Gene Ther; 2006 Feb; 13(2):203-14. PubMed ID: 16082379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted chemotherapy for head and neck cancer with a chimeric oncolytic adenovirus coding for bifunctional suicide protein FCU1.
    Dias JD; Liikanen I; Guse K; Foloppe J; Sloniecka M; Diaconu I; Rantanen V; Eriksson M; Hakkarainen T; Lusky M; Erbs P; Escutenaire S; Kanerva A; Pesonen S; Cerullo V; Hemminki A
    Clin Cancer Res; 2010 May; 16(9):2540-9. PubMed ID: 20388844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.